ConductScience.org, home

Trial · NCT04860011

Registered outcomes60

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryDiuretic effectfrom randomisation to 48 hoursDiuretic effect, as assessed by mean change in weight
PrimaryDiuretic effectfrom randomisation to 72 hoursDiuretic effect, as assessed by mean change in weight
PrimaryDiuretic effectfrom randomisation to 96 hoursDiuretic effect, as assessed by mean change in weight
SecondaryChange in congestion measured by ultrasoundfrom randomisation to 48 hoursChange in congestion, assessed using lung ultrasound as a measure of the sum of B-lines across 8 zones
SecondaryChange in congestion measured by ultrasoundfrom randomisation to 72 hoursChange in congestion, assessed using lung ultrasound as a measure of the sum of B-lines across 8 zones
SecondaryChange in congestion measured by ultrasoundfrom randomisation to 96 hoursChange in congestion, assessed using lung ultrasound as a measure of the sum of B-lines across 8 zones
SecondaryLoop diuretic efficiencyfrom randomisation to 48 hoursLoop diuretic efficiency will be defined as weight loss in kilograms divided by furosemide equivalents in milligrams.
SecondaryLoop diuretic efficiencyfrom randomisation to 72 hoursLoop diuretic efficiency will be defined as weight loss in kilograms divided by furosemide equivalents in milligrams.
SecondaryLoop diuretic efficiencyfrom randomisation to 96 hoursLoop diuretic efficiency will be defined as weight loss in kilograms divided by furosemide equivalents in milligrams.
SecondaryChange in ADVOR clinical congestion scorefrom randomisation to 48 hoursChange in ADVOR clinical congestion score will be measured on a scale of 0 to 10 with 0 being the least congested
SecondaryChange in ADVOR clinical congestion scorefrom randomisation to 72 hoursChange in ADVOR clinical congestion score will be measured on a scale of 0 to 10 with 0 being the least congested
SecondaryChange in ADVOR clinical congestion scorefrom randomisation to 96 hoursChange in ADVOR clinical congestion score will be measured on a scale of 0 to 10 with 0 being the least congested
OtherChange in urinary spot sodiumfrom randomisation to 48 hourschange in urinary spot urine measured in mmol/L
OtherChange in urinary spot sodiumfrom randomisation to 72 hourschange in urinary spot urine measured in mmol/L
OtherChange in urinary spot sodiumfrom randomisation to 96 hourschange in urinary spot urine measured in mmol/L
OtherChange in NT-proBNPfrom randomisation to 48 hoursmeasured in pg/ml
OtherChange in NT-proBNPfrom randomisation to 72 hoursmeasured in pg/ml
OtherChange in NT-proBNPfrom randomisation to 96 hoursmeasured in pg/ml
OtherChange in serum uric acidfrom randomisation to 48 hoursmeasured in umol/L
OtherChange in serum uric acidfrom randomisation to 72 hoursmeasured in umol/L

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04860011/registered